Laboratory specific indicators include AD cerebrospinal fluid biomarker combinations (AB 42, tau, phospho-tau) to calculate the amyloid-tau index, Electroencephalogram, Brain FDG-PET (or SPECT) scan, brain amyloid PET scan, APOE-4 allele, AD deterministic gene mutation detection. The gene discussed is MAPT; the disease is Alzheimer disease.